Pharmaceutical Advocacy & Lobbying Forum
Pursue Optimal Outcomes on Key Federal & State Legislative Issues and Maintaining Compliance
| Type | Conference |
|---|---|
| Language | English |
| Date |
May 22, 2006
to May 23, 2006 |
| Venue |
Arnold & Porter Conference Center 555 Twelfth Street Washington,DC, DC 20004 US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Feliz Exl Pharma 555 Eighth Avenue New York, NY 10018 US 212-400-6240 888-221-6750 fcasanova@exlpharma.com |
| Add event to calendar |
|
Within the dynamic political environment surrounding health policy, it is becoming more important for pharmaceutical, biotech, medical device and healthcare companies to play a larger role in state and federal government legislation in order to have an impact on issues and policies that may effect their organizations. Pharmaceutical and healthcare lobbying efforts topped $123 million in 2004 with an average increase of 10% each year. Almost every major pharmaceutical and healthcare company in the US has been growing their government relations and public affairs teams as a result. With the amount of time, energy, money and resources devoted to this area, there is stronger need for these organizations to establish best practices, form effective partnerships and learn new tactics to have an impact on legislation that is impacting their products and the industry as a whole.
